LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its fi…
Category: Business
Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference Call
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its fi…
My Eyelab, un proveedor líder de salud oftalmológica, se expande en el área de Dallas/Ft. Worth con ocho nuevas tiendas, un crecimiento que creará aproximadamente 50 puestos de trabajo en el área
DALLAS–(BUSINESS WIRE)–My Eyelab, una marca minorista de Now Optics, un proveedor líder de salud oftalmológica que ofrece servicios para el cuidado de la vista y lentes accesibles y económicos, anunció hoy una mayor presencia minorista en ocho locali…
My Eyelab, a Leading Eye Health Provider, Expands in Dallas/Ft. Worth with Eight New Stores, Growth Brings Approximately 50 Jobs to Area
DALLAS–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/EyeExam?src=hash" target="_blank">#EyeExam</a>–My Eyelab, a retail brand of Now Optics, which is a leading eye health provider offering accessible and afford…
Ocular Therapeutix™ Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services
BEDFORD, Mass.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank">$OCUL</a> <a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank">#OCUTX…
Aerie Pharmaceuticals to Announce Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 7, 2019
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Oyster Point Pharma Announces Enrollment of First Subject in Phase 3 Clinical Trial of Nasal Spray for Dry Eye Disease
PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma announces the enrollment of the first subject in the company’s Phase 3 clinical trial of its Nasal Spray for dry eye disease.
Allegro Ophthalmics to Present for the First Time the Results of Its Phase 2 Risuteganib Intermediate Dry Age-Related Macular Degeneration Study at the ASRS Annual Meeting 2019
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/DME?src=hash" target="_blank">#DME</a>–Allegro Ophthalmics announced that the results of its US Phase 2 study evaluating risuteganib for…
Compulink Previews New User Interface for its Ophthalmology SMART EHR at ASRS 2019
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink previews new user interface for its Ophthalmology SMART EHR at ASRS 2019.
Omeros’ OMIDRIA® Receives Product-Specific J-Code from CMS
SEATTLE–(BUSINESS WIRE)–Omeros Corporation today announced that the Centers for Medicare and Medicaid Services (CMS) confirmed its preliminary decision to assign a permanent product-specific Healthcare Common Procedure Coding System (HCPCS) J-code fo…
United States Allergic Conjunctivitis Market & Competitive Landscape: 2014-2019 & 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Allergic Conjunctivitis Market and Competitive Landscape – 2019” report has been added to ResearchAndMarkets.com’s offering. The latest research provides comprehensive insights into Allergic Conjunctivitis pipeline products, Allergic Conjunctivitis epidemiology, Allergic Conjunctivitis market valuations and forecast, Allergic Conjunctivitis drugs sales and competitive landscape in the US. The research is classified into seven sections – Allergic Conjunctivitis t
Visioneering Wins Award of Excellence for Its NaturalVue® Multifocal 1 Day Contact Lenses at Australia’s Largest Eyecare Event
MELBOURNE, Australia–(BUSINESS WIRE)–US-based medical device company Visioneering Technologies Inc. (ASX: VTI) (‘Visioneering’ or ‘The Company’) is pleased to announce that it has received the Award of Excellence for its innovative NaturalVue® (etafi…
GEHA Announces Exclusive Multi-year Partnership With Kansas City Chiefs and Patrick Mahomes
LEE’S SUMMIT, Mo.–(BUSINESS WIRE)–Government Employees Health Association, Inc. (GEHA) today announces a new partnership with the Kansas City Chiefs and Patrick Mahomes, reigning NFL MVP, Chiefs quarterback and new GEHA Official Brand Partner. “GEHA …
United States Wet Age-Related Macular Degeneration Market Report 2019: The Pipeline, Epidemiology, Market Valuations, Drugs (Sales & Market Share), and Competitive Landscape Through 2014-2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Wet Age-Related Macular Degeneration Market and Competitive Landscape – 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights into Wet Age-Related Macular Degeneration pipeline products, Wet Age-Related Macular Degeneration epidemiology, Wet Age-Related Macular Degeneration market valuations and forecast, Wet Age-Related Macular Degeneration drugs sales and competitive landscape in the US. The research is c
Eye Surgery Associates Enters Strategic Partnership With Eyecare Services Partners
DALLAS–(BUSINESS WIRE)–Eye Surgery Associates (“ESA”), one of the leading comprehensive eye care providers in South Florida, has entered into a strategic partnership with Eyecare Services Partners Management, LLC (“ESP”), the leading national provide…
Detailed Review of Tebentafusp (IMCgp100) in Metastatic Uveal Melanoma Published in Issue of Cancers
OXFORD, England & CONSHOHOCKEN, Pa. & ROCKVILLE, Md–(BUSINESS WIRE)–Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announce the publication of “Tebentafusp: T Cell Redirection for the Treatment of Metastatic …
Alcon to Announce Second Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Announce Second Quarter 2019 Results and Host a Conference Call on Wednesday, August 21.
Alcon to Announce Second Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Announce Second Quarter 2019 Results and Host a Conference Call on Wednesday, August 21.
United States Uveitis Market, Drug Outlook, and Competitive Landscape 2014-2019 & 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Uveitis Market and Competitive Landscape – 2019” report has been added to ResearchAndMarkets.com’s offering. US Uveitis Market and Competitive Landscape Highlights – 2019, provides comprehensive insights into Uveitis pipeline products, Uveitis epidemiology, Uveitis market valuations and forecast, Uveitis drugs sales and competitive landscape in the US. The research is classified into seven sections – Uveitis treatment options, pipeline products, market analysis
United States Dry Age-Related Macular Degeneration Market 2014-2019 & 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Dry Age-Related Macular Degeneration Market and Competitive Landscape – 2019” report has been added to ResearchAndMarkets.com’s offering. US Dry Age-Related Macular Degeneration Market and Competitive Landscape Highlights – 2019, provides comprehensive insights into Dry Age-Related Macular Degeneration pipeline products, Dry Age-Related Macular Degeneration epidemiology, Dry Age-Related Macular Degeneration market valuations and forecast, Dry Age-Related Macular